Key facts
- Notable investors include Creative Destruction Lab, University of Toronto, Archangel Network of Funds, Aventure Capital (VC), Capital BioVentures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for HyliDx
- ·The full record, as it builds
Funding rounds
No funding rounds for HyliDx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HyliDx
Operator of a medical diagnostics company intended to support safe and effective assessment and care for critical illnesses anywhere in real-time. The company specializes in developing tools needed to take control of complex diseases, enabling clients to improve the global reach of personalized patient care.
- Sector
- Healthcare
- HQ
- Ottawa, Canada
- Founded
- 2020
- Employees
- 6
- Website
- hylidx.com/
- Ownership
- Privately Held (backing)
HyliDx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HyliDx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HyliDx in its N-PORT filings yet. We sweep new filings monthly.